99 related articles for article (PubMed ID: 14044759)
1. THE ACTIVITY OF A REPOSITORY FORM OF 4,6-DIAMINO-1(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AGAINST INFECTIONS WITH PLASMODIUM CYNOMOLGI.
SCHMIDT LH; ROSSAN RN; FISHER KF
Am J Trop Med Hyg; 1963 Jul; 12():494-503. PubMed ID: 14044759
[No Abstract] [Full Text] [Related]
2. LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG.
THOMPSON PE; OLSZEWSKI BJ; ELSLAGER EF; WORTH DF
Am J Trop Med Hyg; 1963 Jul; 12():481-93. PubMed ID: 14044758
[No Abstract] [Full Text] [Related]
3. POTENTIATION OF ACTIVITY OF DIAPHENYLSULFONE AND PYRIMETHAMINE AGAINST PLASMODIUM GALLINACEUM AND PLASMODIUM CYNOMOLGI BASTIANELLII.
BASU PC; SINGH NN; SINGH N
Bull World Health Organ; 1964; 31(5):699-705. PubMed ID: 14278006
[TBL] [Abstract][Full Text] [Related]
4. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
THOMPSON PE; OLSZEWSKI B; WAITZ JA
Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
[No Abstract] [Full Text] [Related]
5. THE LOCALIZATION OF INFECTIVE PRE-ERYTHROCYTIC FORMS OF PLASMODIUM CYNOMOLGI.
ROSSAN RN; FISHER KF; GREENLAND RD; GENTHER CS; SCHMIDT LH
Trans R Soc Trop Med Hyg; 1964 Mar; 58():159-63. PubMed ID: 14128583
[No Abstract] [Full Text] [Related]
6. Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model.
Edstein MD; Corcoran KD; Shanks GD; Ngampochjana M; Hansukjariya P; Sattabongkot J; Webster HK; Rieckmann KH
Am J Trop Med Hyg; 1994 Feb; 50(2):181-6. PubMed ID: 8116810
[TBL] [Abstract][Full Text] [Related]
7. Effect of certain drugs on exoerythrocytic parasites of Plasmodium cynomolgi.
EYLES DE; COATNEY GR
Am J Trop Med Hyg; 1962 Mar; 11():175-85. PubMed ID: 13891113
[No Abstract] [Full Text] [Related]
8. The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231).
Knight DJ; Mamalis P; Peters W
Ann Trop Med Parasitol; 1982 Feb; 76(1):1-7. PubMed ID: 7044322
[No Abstract] [Full Text] [Related]
9. STUDIES ON A DIHYDROTRIAZINE AND A SULFONE, ALONE AND IN COMBINATION, AGAINST PLASMODIUM BERGHEI IN MICE.
THOMPSON PE; BAYLES A; OLSZEWSKI B; WAITZ JA
Am J Trop Med Hyg; 1965 Mar; 14():198-206. PubMed ID: 14270445
[No Abstract] [Full Text] [Related]
10. 8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria.
Singh C; Kanchan R; Srivastava D; Puri SK
Bioorg Med Chem Lett; 2006 Feb; 16(3):584-6. PubMed ID: 16275088
[TBL] [Abstract][Full Text] [Related]
11. Malaria chemotherapy; the response of trophozoite-induced infections with Plasmodium cynomolgi to various antimalarial drugs.
GENTHER CS; SQUIRES W
Fed Proc; 1948 Mar; 7(1 Pt 1):221. PubMed ID: 18938343
[No Abstract] [Full Text] [Related]
12. 6-(5-NITRO-2-FURYL)-AS-TRIAZINE-3,5(2H,4H)-DIONE. A POTENTIAL URINARY TRACT ANTIBACTERIAL.
HAYES K
J Med Chem; 1964 Nov; 7():819-20. PubMed ID: 14262824
[No Abstract] [Full Text] [Related]
13. Studies on infections with the Berok strain of Plasmodium cynomolgi in monkeys and mosquitoes.
Collins WE; Warren M; Galland GG
J Parasitol; 1999 Apr; 85(2):268-72. PubMed ID: 10219307
[TBL] [Abstract][Full Text] [Related]
14. A strain of monkey malaria (Plasmodium cynomolgi) made resistant to proguanil (paludrine).
HAWKING F; THURSTON JP
Trans R Soc Trop Med Hyg; 1951 Jun; 44(6):695-701. PubMed ID: 14855617
[No Abstract] [Full Text] [Related]
15. Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys.
Shao BR; Ye XY
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):81-3. PubMed ID: 1948265
[TBL] [Abstract][Full Text] [Related]
16. Malaria chemotherapy; the response of sporozoite-induced infections with Plasmodium cynomolgi to various antimalarial drugs.
SCHMIDT LH; FRADKIN R
Fed Proc; 1948 Mar; 7(1 Pt 1):253. PubMed ID: 18934432
[No Abstract] [Full Text] [Related]
17. The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei.
Knight DJ; Williamson P
Ann Trop Med Parasitol; 1982 Feb; 76(1):9-14. PubMed ID: 7044325
[No Abstract] [Full Text] [Related]
18. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta.
Corcoran KD; Hansukjariya P; Sattabongkot J; Ngampochjana M; Edstein MD; Smith CD; Shanks GD; Milhous WK
Am J Trop Med Hyg; 1993 Oct; 49(4):473-7. PubMed ID: 8214277
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 4,6-diamino-1,2-dihydro-2,2'-dialkyl or aryl-1-(substituted)-s-triazines as antimalarial agents.
Khety Z; Kamath V; Renapurkar DM; Khadse BG
Indian J Malariol; 1988 Dec; 25(2):119-24. PubMed ID: 3077369
[No Abstract] [Full Text] [Related]
20. [Studies on the establishment of malarial animal model of short-term relapse. II. The phenomenon of sustained special ring form parasitemia in Plasmodium cynomolgi infection].
Zhang JX; Lin BY; Pan YR; Zheng H; Fang Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(4):250-4. PubMed ID: 1303329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]